UiPath Inc. (NYSE:PATH) Receives Consensus Recommendation of “Hold” from Analysts

Shares of UiPath Inc. (NYSE:PATH) have received a consensus recommendation of “Hold” from the eighteen brokerages that are currently covering the company, MarketBeat reports. Sixteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $17.47.

A number of research analysts recently commented on the company. Wells Fargo & Company lowered their price target on UiPath from $15.00 to $13.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd. Barclays boosted their target price on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a report on Friday, September 6th. Bank of America raised their target price on shares of UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. JPMorgan Chase & Co. decreased their price target on shares of UiPath from $19.00 to $17.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 23rd. Finally, Evercore ISI raised their price objective on UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a research report on Friday, September 6th.

Insider Buying and Selling at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the sale, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at $10,258,498.19. This represents a 5.31 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 22.37% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in PATH. Global Financial Private Client LLC lifted its position in shares of UiPath by 9.3% in the 1st quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock worth $144,000 after purchasing an additional 551 shares during the period. Advisors Asset Management Inc. raised its stake in UiPath by 35.0% in the first quarter. Advisors Asset Management Inc. now owns 3,037 shares of the healthcare company’s stock worth $69,000 after buying an additional 787 shares in the last quarter. Cowa LLC lifted its holdings in UiPath by 4.4% during the third quarter. Cowa LLC now owns 26,681 shares of the healthcare company’s stock worth $342,000 after buying an additional 1,118 shares during the period. Nations Financial Group Inc. IA ADV boosted its position in UiPath by 6.8% during the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 26,090 shares of the healthcare company’s stock valued at $334,000 after acquiring an additional 1,654 shares in the last quarter. Finally, Amalgamated Bank boosted its position in UiPath by 7.1% during the 3rd quarter. Amalgamated Bank now owns 27,312 shares of the healthcare company’s stock valued at $350,000 after acquiring an additional 1,811 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Trading Up 1.9 %

Shares of PATH stock opened at $12.76 on Wednesday. The stock has a market capitalization of $7.01 billion, a P/E ratio of -63.77 and a beta of 0.87. The firm’s 50 day moving average is $12.63 and its 200 day moving average is $13.25. UiPath has a 12-month low of $10.37 and a 12-month high of $27.87.

UiPath (NYSE:PATH) last announced its earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The business had revenue of $316.00 million during the quarter, compared to analysts’ expectations of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The firm’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the company earned ($0.09) earnings per share. As a group, equities analysts predict that UiPath will post -0.23 earnings per share for the current year.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.